Protection of three strains of mice against lethal influenza in vivo by defective interfering virus
- PMID: 8212859
- DOI: 10.1016/0168-1702(93)90058-u
Protection of three strains of mice against lethal influenza in vivo by defective interfering virus
Abstract
This report examines the protective effects of defective interfering (DI) WSN on three strains of mice (C3H/He-mg (H-2k), C57BL/6 (H-2b) and BALB/c (H-2d)) infected with various doses of A/WSN influenza virus. All three strains were protected in terms of morbidity and mortality, to varying extents, DI WSN protected optimally against a low but lethal dose of A/WSN in C3H/He-mg mice, but also protected this and other strains against very high doses of A/WSN. Intermediate sized inocula gave little, if any, protection. In all cases protection required an active DI genome since inactivation with beta-propiolactone abrogated any sparing effect. Consolidation of the lungs was reduced by treatment with active DI virus, but at some doses of inoculum there was reduction in lung pathology without reduction of mortality. Treatment of infected mice with DI virus did not reduce the lung virus titre, but in C3H/He-mg mice resulted in recovery of infectious virus from other tissues, notably the heart, where it was not normally found. No infectivity was recovered from brain, liver or serum. Haemagglutination-inhibiting (HI) antibody could not be detected in the lungs of any of the infected mice co-inoculated with the control BPL-inactivated DI WSN but was present in considerable amounts in all three strains when these were co-inoculated with DI virus. These and previous data (Morgan and Dimmock, 1992) suggested that influenza virus was immunosuppressive and that active DI virus abrogated these suppressive effects.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.Vaccine. 2011 Sep 2;29(38):6584-91. doi: 10.1016/j.vaccine.2011.06.114. Epub 2011 Jul 14. Vaccine. 2011. PMID: 21762748 Free PMC article.
-
Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.Virology. 1998 Sep 1;248(2):241-53. doi: 10.1006/viro.1998.9267. Virology. 1998. PMID: 9721233
-
Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.J Gen Virol. 1986 May;67 ( Pt 5):839-50. doi: 10.1099/0022-1317-67-5-839. J Gen Virol. 1986. PMID: 2422317
-
Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.J Gen Virol. 1989 Oct;70 ( Pt 10):2615-24. doi: 10.1099/0022-1317-70-10-2615. J Gen Virol. 1989. PMID: 2794973
-
Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.J Gen Virol. 1994 Dec;75 ( Pt 12):3485-91. doi: 10.1099/0022-1317-75-12-3485. J Gen Virol. 1994. PMID: 7996140
Cited by
-
Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.PLoS Pathog. 2013 Oct;9(10):e1003703. doi: 10.1371/journal.ppat.1003703. Epub 2013 Oct 31. PLoS Pathog. 2013. PMID: 24204261 Free PMC article.
-
Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.Vaccine. 2011 Sep 2;29(38):6584-91. doi: 10.1016/j.vaccine.2011.06.114. Epub 2011 Jul 14. Vaccine. 2011. PMID: 21762748 Free PMC article.
-
Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?J Virol. 2014 May;88(10):5217-27. doi: 10.1128/JVI.03193-13. Epub 2014 Feb 26. J Virol. 2014. PMID: 24574404 Free PMC article. Review.
-
Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus.Nature. 2013 Nov 21;503(7476):406-9. doi: 10.1038/nature12637. Epub 2013 Oct 20. Nature. 2013. PMID: 24141948 Free PMC article.
-
Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.Antiviral Res. 2012 Dec;96(3):376-85. doi: 10.1016/j.antiviral.2012.09.017. Epub 2012 Oct 4. Antiviral Res. 2012. PMID: 23041142 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases